An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19
- DOI
- 10.1021/acsptsci.0c00106
- Published
- 2020-09-07
- Container
- ACS Pharmacology & Translational Science
- Publisher
- American Chemical Society (ACS)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1021/acsptsci.0c00106,
title = {An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19},
author = {Jonathan H. Shrimp and Stephen C. Kales and Philip E. Sanderson and Anton Simeonov and Min Shen and Matthew D. Hall},
year = {2020},
journal = {ACS Pharmacology \& Translational Science},
doi = {10.1021/acsptsci.0c00106},
url = {https://doi.org/10.1021/acsptsci.0c00106}
}RIS
TY - JOUR TI - An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19 AU - Jonathan H. Shrimp AU - Stephen C. Kales AU - Philip E. Sanderson AU - Anton Simeonov AU - Min Shen AU - Matthew D. Hall PY - 2020 JO - ACS Pharmacology & Translational Science DO - 10.1021/acsptsci.0c00106 UR - https://doi.org/10.1021/acsptsci.0c00106 ER -
APA
Shrimp, J. H., Kales, S. C., Sanderson, P. E., Simeonov, A., Shen, M., & Hall, M. D. (2020). An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19. ACS Pharmacology & Translational Science. https://doi.org/10.1021/acsptsci.0c00106
Source records
- crossref · retrieved 2026-09-26T13:26:05.457Z